Effects of Ginsenoside Rb1 on Skin Changes by Kimura, Yoshiyuki et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 946242, 11 pages
doi:10.1155/2012/946242
Review Article
Effectsof Ginsenoside Rb1 on Skin Changes
YoshiyukiKimura,1 Maho Sumiyoshi,2 andMasahiroSakanaka2
1Division of Biochemical Pharmacology, Department of Basic Medical Research, Ehime University Graduate School of Medicine,
Shitsukawa, Toon City, Ehime 791-0295, Japan
2DivisionofFunctionalHistology,DepartmentofFunctionalBiomedicine,EhimeUniversityGraduateSchoolofMedicine,Shitsukawa,
Toon City, Ehime 791-0295, Japan
Correspondence should be addressed to Yoshiyuki Kimura, yokim@m.ehime-u.ac.jp
Received 26 July 2011; Revised 26 October 2011; Accepted 2 November 2011
Academic Editor: Ikhlas A. Khan
Copyright © 2012 Yoshiyuki Kimura et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Ginseng roots (Panax ginseng CA Meyer) have been used traditionally for the treatment, especially prevention, of various diseases
inChina,Korea,andJapan.Bothexperimentalandclinicalstudiessuggestginsengrootstohavepharmacologicaleﬀectsinpatients
withlife-style-relateddiseasessuchasnon-insulin-dependentdiabeticmellitus,atherosclerosis,hyperlipidemia,andhypertension.
The topical use of ginseng roots to treat skin complaints including atopic suppurative dermatitis, wounds, and inﬂammation is
alsodescribedinancientChinesetexts;however,therehavebeenrelativelyfewstudiesinthisarea.Inthepresentpaper,wedescribe
introduce the biological and pharmacological eﬀects of ginsenoside Rb1 isolated from Red ginseng roots on skin damage caused
by burn-wounds using male Balb/c mice (in vivo) and by ultraviolet B irradiation using male C57BL/6J and albino hairless (HR-1)
mice (in vivo). Furthermore, to clarify the mechanisms behind these pharmacological actions, human primary keratinocytes and
the human keratinocyte cell line HaCaT were used in experiments in vitro.
1.Introduction
The oral administration of red ginseng root (P. ginseng)
extracts has long been used to treat various diseases, includ-
ing liver and kidney dysfunction, hypertension, non-insulin-
dependent diabetes mellitus, and postmenopausal disorders,
in China, Korea, and Japan. Topical applications have also
been used for atopic suppurative dermatitis, wounds, and
skin inﬂammation. The materials for Korean red ginseng
products are selected from among ginseng roots (Panax
ginseng CA Meyer) carefully cultivated in well-fertilized
ﬁeld for 6 years and then steamed and dried in the sun
six times. The red ginseng extract produced by Korea
Ginseng Corporation (Taejon, Korea) is dried and powdered
by freezing prior to use. In this paper, we introduce the
biological and pharmacological eﬀects of ginsenoside Rb1
isolated from red ginseng roots on skin damage in mice.
2. Effects of GinsenosideRb1 on
BurnWoundHealinginMice
Burns and wounds initially induce coagulative necrosis and
cause the formation of a scar. Macrophages migrate to
an injured area to kill invading organisms and produce
cytokines that recruit other inﬂammatory cells responsible
for the diverse eﬀects of inﬂammation [1, 2]. Angiogenesis
in the injured area is closely associated with the pro-
cess of wound healing [3]. Moreover, growth factors and
cytokines are central to the wound-healing process [4–6].
Thus, the burn wound-healing process is complex, involving
inﬂammatory factors, including monocyte migration and
cytokine production, and growth factors and angiogenesis
duringreepithelialization.Vascularendothelialgrowthfactor
(VEGF) plays an important role in skin tissue repair
through angiogenesis during the healing of burn wounds2 Journal of Biomedicine and Biotechnology
Table 1: Eﬀects of various ginseng saponins on angiogenesis.
Eﬀects of ginsenoside Rb2 (100μg/mouse, iv) on tumor-induced angiogenesis in B16-BL6 melanoma-inoculated mice (in vivo)
Ginsenoside Rb2 showed antiangiogenesis [25].
Eﬀects of ginsenoside Rb2 (100μg/mouse, iv and 300μg/mouse, po), 20(R)Rg3 (100μg/mouse, iv and 300μg/mouse, po), and 20(S)Rg3
(100μg/mouse, iv and 300μg/mouse, po) on tumor-induced angiogenesis in B16-BL6 melanoma-inoculated mice (in vivo).
Ginsenoside Rb2, 20(R)Rg3 and 20(S)Rg3, showed antiangiogenesis [40].
Eﬀects of the total saponin fraction (10–100μg/mL) on tube formation by HUVECs (in vitro).
The total saponin fraction enhanced angiogenesis [22].
Eﬀects of ginsenoside Rg1 (10μM) and Rb1 (10μM) on angiogenesis in scaﬀold implants in mice (in vivo).
Eﬀects of Rg1 (125nM) and Rb1 (125nM) on chemoinvasion in HUVEC (in vitro).
Ginsenoside Rg1 enhanced angiogenesis, and ginsenoside Rb1 showed antiangiogenesis in the earliest stage [23].
Eﬀects of ginsenoside Re (10–100μg/mL) on angiogenesis in HUVECs (in vitro).
Eﬀects of Re (70μg/extracellular matrix) on angiogenesis in extracellular matrix-implanted rats (in vivo).
Ginsenoside Re showed angiogenesis [41].
Eﬀects of ginsenoside Rg1 (150–600nM) on angiogenesis in HUVECs (in vitro).
Eﬀects of Rg1 (600nM/Matrigel) on angiogenesis in Matrigel-implanted mice (in vivo).
Ginsenoside Rg1 promoted angiogenesis [42].
Eﬀects of 20(R)-ginsenoside Rg3(1-1000nM) on angiogenesis in HUVECs (in vivo).
20(R)-ginsenoside Rg3 showed antiangiogenesis [43].
Eﬀects of Ginsenoside Rg1 (150nM) on angiogenesis in HUVECs (in vitro).
Ginsenoside Rg1 promoted angiogenesis [44].
Eﬀects of ginsenoside Rg1 (30μg/mL) and Re (30μg/mL) on angiogenesis in HUVECs (in vitro).
Eﬀects of Rg1 (50μg/mL) and Re (50μg/mL) on angiogenesis in Matrigel-implated mice (in vivo).
Ginsenoside Rg1and Re promoted angiogenesis [45].
Eﬀects of ginsenoside Rg3 (3mg/kg, ip) on growth and angiogenesis of ovarian cancer (in vivo).
Ginsenoside Rg3 showed antiangiogenesis [46].
Eﬀects of ginsenoside Rb1 (250nM) on angiogenesis in HUVECs (in vitro).
Ginsenoside Rb1 showed antiangiogenesis [47].
Eﬀects of ginsenoside Rg1 (500μg/Matrigel) on angiogenesis in Matrigel-implanted mice (in vivo)
Ginsenoside Rg1 promoted angiogenesis [48].
Eﬀects of saponins (0.1–100μg/mL) isolated from Panax notoginseng and Rg1(10μg/mL) on angiogenesis in HUVECs (in vitro).
Total saponin and ginsenoside Rg1 promoted angiogenesis [49].
Eﬀects of ginsenoside Rg3 (20mg/kg, po) on angiogenesis and growth in lung carcinoma-implanted mice.
Ginsenoside Rg3 showed antiangiogenesis [50].
[4, 7, 8]. Furthermore, it has been demonstrated that
chemokines including macrophage inﬂammatory protein-
1α (MIP-1α) and monocyte chemoattractant protein-1
(MCP-1)areexpressedathighlevelsinmurinefull-thickness
dermal wounds at times preceding and coinciding with
maximal macrophage inﬁltration [9–12]. Interleukin 1-β
(IL-1β) is also known to be released from monocyte-
derived macrophages during inﬂammation and stimulates
VEGF expression in endothelial cells, keratinocytes, synovial
ﬁbroblasts, and colorectal carcinoma cells [13–16]. IL-1β
gene expression was reported to be upregulated in MCP-
1-treated human monocytes [17]. Trautmann et al. [18]
found that the expression of MCP-1 of macrophage and
keratinocyte origin correlated with the accumulation of mast
cells during wound healing. Weller et al. [19] reported that
mast cell activation and histamine release were required for
wound healing. Numata et al. [20] showed that the acceler-
ated wound-repair activity of histamine was mediated by the
activity of basic ﬁbroblast growth factor (bFGF), which leads
to angiogenesis, and macrophage recruitment in the wound-
healingprocess.Thus,theprocessofwoundrepairisthought
to be closely associated with the network systems among
various cells such as keratinocytes, ﬁbroblasts, macrophages
and mast cells, and might be modulated by interactions
among chemokines, cytokines, growth factors, and related
biofactors secreted from these cells.
The genus Panax derives its name from the Greek
words pan (all) and akos (healing). In 1988, Kanzaki et
al. [21] reported that an orally administered red ginseng
root extract stimulated the repair of intractable skin ulcers
in patients with diabetes mellitus and Werner’s syndrome
in clinical trials. Morisaki et al. [22] showed that the
local administration of ginseng saponins markedly improved
wound healing in diabetic and aging rats. Sengupta et al.
[23] reported that ginsenoside Rg1 promoted functional
angiogenesis into a polymer scaﬀold (in vivo) and the
proliferation and chemoinvasion of tube-like capillary for-
mationbyhumanumbilicalveinendothelialcells(HUVECs)
through enhanced expression of nitric oxide synthetase,
phosphatidylinositol-3 kinase, and the Akt pathway (in
vitro). Conversely ginsenoside Rb1 inhibited the earliest
step in angiogenesis, the chemoinvasion of HUVECs [23].
Furthermore, Choi [24] reported that ginsenoside Rb2
improved wound healing through its facilitating eﬀects onJournal of Biomedicine and Biotechnology 3
R1O
R2O
HO
3
20
R1O
R2O
HO
3
20
Ginsenoside Rb1:R 1
Ginsenoside Rb2:R 1
Ginsenoside Rc: R1
Ginsenoside Rd: R1 = -Glc
(p): pyranosyl, (f): furanosyl
Ginsenoside Re: R1
Ginsenoside Rg1:R 1
20 (S) protopanaxadiol-type
20 (S) protopanaxatriol-type
= -Glc2-Glc, R2 = -Glc6-Glc
= -Glc2-Glc, R2 = -Glc6-Ara (p)
= -Glc2-Glc, R2
= -Glc2-Glc, R2
= -Glc6-Ara (f)
= -Rham, R2 = -Glc
= -H, R2 = -Glc
O-Glc-R1
Figure 1: The structure of various ginsenosides.
Table 2: Eﬀects of ginsenoside Rb1 on angiogenesis from the area
surrounding burn wounds in mice [26].
Treatment Blood vessel length
(mm/ﬁeld)
Blood vessel area
(mm2/ﬁeld)
Untreated burn wounds
(control) 75.6 ±24.91 0 .5 ±3.8
+Ginsenoside Rb1
(100fg/wound) 228.8 ±38.6∗ 46.6 ±15.0∗
(10pg/wound) 203.0 ±17.0∗ 37.6 ±5.5∗
(1ng/wound) 274.1 ±37.4∗ 49.9 ±4.7∗
+bFGF 241.5 ±28.3∗ 35.8 ±5.9∗
The burn wounds were created on the backs of male Balb/c mice (6 weeks
old) under anesthesia with pentobarbital. A polyethylene ﬁlter pellet (about
8mm in diameter, 3mm thick) containing the indicated amount of basic
ﬁbroblast growth factor (bFGF) or ginsenoside Rb1 was applied to the burn
wound surface. On day 9, any angiogenesis in the site surrounding the burn
wound was photographed using a stereoscopic microscope, and the area
and length of blood vessels were measured using a Coordinating Area and
Curvimeter Machine (X-PLAN 360 dII, Ushitaka, Tokyo, Japan).
Values are the mean ± SE for six mice. ∗Signiﬁcantly diﬀerent from
untreated burn wounds (control), P<0.05.
epidermal cell proliferation, by upregulating the expression
of proliferation-related factors. However, Sato et al. [25]
found that the intravenous administration of ginsenoside
Rb2 inhibited metastasis to the lung by inhibiting tumor-
induced angiogenesis in B16-BL6 melanoma-bearing mice.
Thus, there are perplexing contradictions in the reported
eﬀects of various ginseng saponins on angiogenic activity as
shown in Table 1.
To clarify these diﬀering eﬀects, we ﬁrst attempted to
examine the eﬀects of various ginseng saponins on wound
healing. Among six ginseng saponins (ginsenoside Rb1,R b 2,
Rc, Rd, Re, and Rg1)( Figure 1), we found that ginsenoside
Rb1 enhanced burn-wound healing most strongly.
In summary, we reported the promotion of burn-
wound healing by the topical application of ginsenoside
Rb1 at low doses (100fg, 10pg, and 1ng per wound) to be
due to the promotion of angiogenesis during skin wound
repair through stimulation of VEGF production and an
increase in hypoxia-inducible factor (HIF-) 1α expression
in keratinocytes and the elevation of interleukin (IL-) 1β
from macrophage accumulation in the burn wound area
[26]. Furthermore, we found the facilitating eﬀects of
ginsenoside Rb1 at low doses (100fg, 10pg, and 1ng per
wound) to be due to the promotion of angiogenesis via the
activation of basic ﬁbroblast growth factor (bFGF) through
an increase in histamine released from mast cells recruited
by the stimulation of monocyte chemoattractant protein-1
(MCP-1) as another mechanism [27]. We will explain our
experiments regarding the facilitating eﬀects of ginsenoside
Rb1 on burn-wound healing in detail. The burn area in
mice treated with a topical application of ginsenoside Rb1 in
the range of 10−8%t o1 0 −12% was signiﬁcantly reduced on
days 8–20 compared to that in vehicle-treated burn-wound
control mice (Figure 2).
To clarify the mechanism behind the facilitating eﬀect of
ginsenoside Rb1 on wound healing, we examined levels of
IL-1β andVEGFinexudatesoftheburn.Thelevelsincreased
with time over 9 days. At 1ng of ginsenoside Rb1 per wound,
the level of IL-1β was increased on days 1, 3, and 5 but
signiﬁcantly decreased on day 9 compared to that in vehicle-
treated control mice (Figure 3). The topical application of
bFGF (2.5μg per wound) also increased IL-1β production
on day 3. The VEGF level in the exudates from the wound4 Journal of Biomedicine and Biotechnology
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Figure 2: Eﬀects of ginsenoside Rb1 on wound healing in mice [26]. After the burn wound was made by applying a customized soldering
iron to the skin on the backs of male Balb/c mice (6 weeks old) for 10s at 250◦C, a sterile biopsy punch (8mm diameter) was used to excise
the burnt skin, leaving the underlying fasciae intact. All surgical treatments were performed under anesthesia with pentobarbital. Indicated
amounts of ginsenoside Rb1 were applied to the burn wounds surface and then covered with a ﬁlm dressing for 19 consecutive days. The
burn wound site was photographed every other day and burn wound area was measured using a Coordinate Area and Curvimeter Machine
(X-PLAN 360 dII). Values are the mean ± SE for 6–12 mice. ∗Signiﬁcantly diﬀerent from vehicle-treated mice, P<0.05.
Table 3: Eﬀects of Panax ginseng e x t r a c to ns k i na g i n g .
Eﬀects of the total ginseng saponin fraction (100 to 500μg/mL) on luciferase reporter gene assays in human dermal ﬁbroblast (in vitro).
Eﬀects of the total ginseng saponin fraction (100 to 500μg/mL) on type I collagen in human dermal ﬁbroblast (in vitro).
The total saponin fraction (100 to 500μg/mL) increased type I procollagen synthesis [51].
Eﬀects of red ginseng extract (20 and 60mg/kg, po) on acute UVB-induced skin aging in mice
The extract inhibited the increases in epidermis and dermis thickness induced by UVB [52].
Eﬀects of red ginseng extract (20mg/kg, ip or topical application of 0.2% cream) on chronic UVB-irradiated skin damage in hairless mice.
The extract reduced wrinkling and tumor incidence [53].
Eﬀects of ginsenoside Rb1 (100 fg, 10pg, or 1ng/mouse, topical application) on chronic UVB-irradiated skin aging in hairless mice.
Ginsenoside Rb1 inhibited the increase in skin thickness, wrinkling, and epidermis in UVB-irradiated hairless mice [31].
Eﬀects of red ginseng extract (a diet containing 0.5 and 2.5% red ginseng extract) on UVB-irradiated skin aging in hairless mice.
The extract reduced wrinkling, the mRNA level of procollagen type I, and the MMP-1 level [54].
Healthy female volunteers over 40 years of age were randomized in a double-blind fashion to receive either red ginseng extract (3g/day) or
placebo for 24 weeks. (Clinical study).
Red ginseng extract caused an improvement in facial wrinkling and increase in type I procollagen synthesis [55].Journal of Biomedicine and Biotechnology 5
0
0.5
1.0
1.5
2.0
2.5
Day
13
Untreated burn wound 
(control)
+bFGF(2.5 mg/wound)
+Rb1(100 fg/wound)
+Rb1(10 pg/wound)
+Rb1(1 ng/wound)
I
L
-
1
β
(
n
g
/
m
g
 
p
r
o
t
e
i
n
) ∗
∗
∗∗
∗
579
Figure 3:EﬀectsofginsenosideRb1 andbFGFonIL-1β production
in the exudates of burns in male Balb/c mice [26]. The burn
wounds were created on the backs of male Balb/c mice (6 weeks
old)underanesthesiawithpentobarbital.Apolyethyleneﬁlterpellet
(about 8 in mm diameter, 3mm thick) containing the indicated
amount of basic ﬁbroblast growth factor (bFGF) or ginsenoside
Rb1 was applied to the burn wounds surface. On days 1, 3, 5, 7,
and 9, the ﬁlter pellets were removed and replaced with fresh ﬁlter
pellets. For control mice, ﬁlter pellets containing saline alone were
applied according to the same schedule. Immediately after removal,
phosphate-buﬀered saline (PBS, pH 7.0) (200μl) was added to each
ﬁlter pellet and mixed for 10min. The IL-1β levels in the ﬁlter
pellets were measured using a mouse IL-1β ELISA kit. Values are
the mean ± SE for 6 mice. ∗Signiﬁcantly diﬀerent from control,
P<0.05.
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Figure 4: Eﬀects of ginsenoside Rb1 and bFGF on VEGF pro-
duction in the exudates of burns in male Balb/c mice [26]. The
experimentswereperformedasdescribedinFigure 3,andtheVEGF
levels in the ﬁlter pellets were measured using a mouse IL-1β ELISA
kit. Values are the mean ± SE for 6 mice. ∗Signiﬁcantly diﬀerent
from control, P<0.05.
Table 4: Eﬀects of ginsenoside Rb1 on the thickness of the
epidermis and extracellular matrix (ECM) of the dermis at week
12 in UVB-irradiated hairless mice [31].
Epidermis (μm) ECM (μm) in
dermis
Normal mice 14.74 ±1.11∗ 332.51 ±23.18∗
Vehicle-treated
UVB-irradiated mice
(control)
142.59 ±25.37 632.32 ±31.96
+Ginsenoside Rb1
(100 fg/mouse) 46.00 ±6.26∗ 561.86 ±45.22
(10pg/mouse) 49.24 ±4.73∗ 560.67 ±44.81
(1ng/mouse) 39.84 ±6.26∗ 585.63 ±31.35
The initial dose of UVB was set at 36mJ/cm2, which was subsequently
increased to 54mJ/cm2 at weeks 1–4, 72mJ/cm2 at weeks 4–7, 108mJ/cm2
at weeks 7–10, and ﬁnally to 122mJ/cm2 at weeks 10–12 in male albino
hairless HOS: HR-1 mice. The frequency of UVB irradiation was set at
three times per week. Ginsenoside Rb1 (100 fg, 10pg, and 1ng/mouse)
was applied topically to the dorsal region of each mouse every day for 12
weeks. The dorsal skin samples (about 3cm2) removed at week 12 were
ﬁxed in 10% buﬀered formalin, embedded in paraﬃn, sectioned at 5μm
thickness, deparaﬃnized, and stained with hematoxylin-eosin (HE) and
Azan. Four diﬀerent microscopic ﬁelds (×200 magniﬁcation) per plate were
photographed. The thickness of the epidermis and dermis thickness were
measured from the samples stained by HE and Azan, using a Digimatic
Caliper.
Values are the mean ± SE for 6 mice. ∗Signiﬁcantly diﬀerent from UVB-
irradiated hairless mice (control), P<0.05.
Table 5: Eﬀects of ginsenoside Rb1 on the numbers of apoptotic
and 8-OHdG-positive cells at week 12 inthe skin ofUVB-irradiated
hairless mice [31].
Apoptotic cells
(number/ﬁeld)
8-OHdG-positive
cells (number/ﬁeld)
Normal mice 0 ±0∗ 106 ±7∗
Vehicle-treated
UVB-irradiated mice
(control)
102 ±10 286 ±32
+Ginsenoside Rb1
(100fg/mouse) 19 ±11∗ 150 ±24∗
(10pg/mouse) 11 ±11∗ 183 ±27∗
(1ng/mouse) 9 ±9∗ 109 ±26∗
GinsenosideRb1 (100fg,10pg,and1ng/mouse)wasappliedtopicallytothe
dorsal region of each mouse every day for 12 weeks. The expression levels
of apoptotic cells and 8-hydroxy-2 -deoxyguanosine (8-OHdG) (marker of
oxidative DNA damage) in the dorsal skin of UVB-irradiated hairless mice
were examined by the TUNEL method using an apoptosis in situ detection
kit and an immunoperoxidase technique using anti-8-OHdG antibody.
Values are the mean ± SE for 6 mice. ∗Signiﬁcantly diﬀerent from UVB-
irradiated mice (control), P<0.05.
increased until day 5 and then decreased. The application
of ginsenoside Rb1 increased VEGF levels on days 1 and 9
(Figure 4). However, the application of bFGF did not aﬀect
VEGF production.
The application of bFGF (2.5μg per wound) or ginseno-
side Rb1 (100fg, 10pg, and 1ng per wound) for 9 days
increased the length of blood vessels by 3- to 3.5-fold and6 Journal of Biomedicine and Biotechnology
Untreated burn wound mice (control) Ginsenoside Rb1(100 fg/wound)
Ginsenoside Rb1(10 pg/wound) Ginsenoside Rb1(1 ng/wound)
5 mm
+bFGF (2.5 μg/wound)
Figure 5: Photographs showing neovascularization from the tissue surrounding the burn and the eﬀects of the topical application of
ginsenoside Rb1 [26]. The experiments were performed as described in Figure 3. On day 9, any angiogenesis in the site surrounding the
burn wound was photographed using a stereoscopic microscope.
the corresponding area by 3.5- to 5.0-fold, compared to the
control (Figure 5 and Table 2).
Ginsenoside Rb1 at concentrations from 100fg/mL to
1ng/mLenhancedtheVEGFproductionandHIF-1αexpres-
sion induced by IL-1β in the human keratinocyte cell line
HaCaT (Figure 6).
These ﬁndings suggest the enhancement of wound
healing by ginsenoside Rb1 to be due to the promotion of
angiogenesis during the repair process as a result of the
stimulation of VEGF production caused by the increase in
HIF-1α expression in keratinocytes. Furthermore, the MCP-
1 level in the exudates of vehicle-treated (control) mice
reached a maximum 1 day after the burn treatment and
declined rapidly from day 3. Ginsenoside Rb1 (1ng per
wound) and bFGF (2.5μg perwound) signiﬁcantly increased
the level of MCP-1 on day 1 compared to that in control
mice (Figure 7). Histamine levels in the exudates of the
burn wound area increased until day 7. Ginsenoside Rb1
(1ng per wound) signiﬁcantly increased the histamine level
on day 5 compared to that in control mice (Figure 7).
Furthermore, ginsenoside Rb1 (100fg, 10pg, and 1ng per
wound) and bFGF (2.5μg perwound) signiﬁcantly increased
histamine production on day 7 (Figure 7). The facilitating
eﬀects of ginsenoside Rb1 may be due to the promotion
of angiogenesis via the activation of bFGF through the
increase in histamine released from mast cells recruited by
the stimulation of MCP-1 production.
Based on these experimental results, the enhancing
eﬀects of ginsenoside Rb1 on burn wound healing are
summarized in Figure 8.
It has been reported that ginsenoside Rb2 as well as
ginsenoside Rb1 promotes wound healing [24].
3. Effects of GinsenosideRb1 on
UltravioletB(UVB-)IrradiatedSkin
DamageinMice
The symptoms of cutaneous aging, such as wrinkles and
pigmentation, for example, develop earlier in sun-exposed
skin than in unexposed skin, a phenomenon referred to as
photoaging. UltravioletB (UVB) radiation is oneof themost
important environmental factors because of its hazardous
eﬀects, which include the generation of skin cancer [28],
suppression of the immune system [29], and premature skin
aging [30].Journal of Biomedicine and Biotechnology 7
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Figure 6: Eﬀects of ginsenoside Rb1 on VEGF production (a) and HIF-1α expression (b) with or without IL-1β in HaCaT cells [26].
The human keratinocyte cell line HaCaT was treated with the indicated amounts of ginsenoside Rb1 in the presence or absence of IL-1β
(20ng/mL) for 1 or 2h. VEGF levels in the medium were measured using a human VEGF kit. The expression of hypoxia-inducible factor
(HIF-) 1α in the nuclear fraction of HaCaT cells was measured by western blot analysis with mouse anti-HIF-1α and anti-β-actin antibodies.
Values are the mean ± SE for six experiments. ∗Signiﬁcantly diﬀerent from control, P<0.05.
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Figure 7: Eﬀects of ginsenoside Rb1 and bFGF on MCP-1 (a) and histamine (b) production in the exudates of burns in male Balb/c mice
[27]. The experiments were performed as described in Figure 3, and then MCP-1 and histamine levels in the ﬁlter pellets were measured
using mouse MCP-1 and histamine ELISA kits, respectively. Values are the mean ± SE for 6 mice. ∗Signiﬁcantly diﬀerent from control,
P<0.05.8 Journal of Biomedicine and Biotechnology
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Figure 8: The proposed mechanisms of the enhancing eﬀects of
ginsenoside Rb1 on burn wound healing.
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Figure 9: Eﬀects of ginsenoside Rb1 on skin thickness in chronic
UVB-irradiated male hairless (HRM-1) mice [31]. The initial dose
o fU V Bw a ss e ta t3 6 m J / c m 2, which was subsequently increased
to 54mJ/cm2 at weeks 1–4, 72mJ/cm2 at weeks 4–7, 108mJ/cm2
at weeks 7–10, and ﬁnally 122mJ/cm2 at weeks 10–12 in male
albino hairless HOS: HR-1 mice. The frequency of UVB irradiation
was set at three times per week. Ginsenoside Rb1 (100 fg, 10pg,
and 1ng/mouse) was applied topically to the dorsal region of each
mouse every day for 12 weeks. The dorsal skin of the hairless
mice was lifted up by pinching gently under anesthetization with
pentobarbital, and skin-fold thickness was measured using a Quick
Mini caliper. Skin thickness after UVB irradiation was measured
every week. Values are the mean ± SE for 6 mice. ∗Signiﬁcantly
diﬀerent from vehicle-treated mice, P<0.05.
AsshowninTable 3,ithasbeenreportedthatredginseng
extract prevents skin aging induced by UVB irradiation.
However, the active substance(s) has yet to be identiﬁed.
We found that ginsenoside Rb1 isolated from red ginseng
rootsinhibitedtheincreasesinskinthickness,epidermis,and
wrinkle formation induced by chronic UVB irradiation [31].
In this paper, we will introduce the eﬀects of ginsenoside
Rb1 on chronic UVB irradiation-induced cutaneous aging in
hairless mice.
ThetopicalapplicationofginsenosideRb1 atlowerdoses,
100fg, 10pg, and 1ng/mouse, signiﬁcantly inhibited the
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Figure 10: Eﬀects of ginsenoside Rb1 on skin elasticity in chronic
UVB-irradiatedmalehairless(HRM-1)mice[31].Theexperiments
were performed as described in Figure 9. The dorsal skin was lifted
up and skin stretch was measured using a digimatic caliper. Skin
elasticity after UVB irradiation was measured every week. Values
are the mean ± SE for 6 mice. ∗Signiﬁcantly diﬀerent from vehicle-
treated mice, P<0.05.
increaseinskinthicknessinducedbyUVBirradiationduring
weeks 2 to 12 compared to the skin thickness of vehicle-
treated UVB-irradiated mice (control) (Figure 9).
The reduction in skin elasticity induced by UVB irradi-
ation was signiﬁcantly inhibited by the topical application
of ginsenoside Rb1 (100fg, 10pg, and 1ng/mouse) during
weeks 6 to 12 compared to that of control mice (Figure 10).
Wrinkling induced by UVB irradiation at week 9 was
inhibited by the topical application of ginsenoside Rb1
(100fg, 10pg, and 1ng/mouse) (Figure 11).
The topical application of ginsenoside Rb1 (100fg, 10pg,
and 1ng/mouse) inhibited the increase in epidermal thick-
ness induced by UVB irradiation but had no eﬀect on the
increase in the extracellular matrix of the dermis (Table 4).
Theoccurrenceofapoptoticcellswaslocalizedtothestratum
granulosum of the epidermis and was increased by UVB
irradiation.TheincreaseinapoptoticcelllevelsinducedUVB
irradiation was signiﬁcantly inhibited by ginsenoside Rb1
(100fg. 10pg, and 1ng/mouse). Furthermore, 8-hydroxy-
2 -deoxyguanosine (8-OHdG, a marker of oxidative DNA
damage) [32] was also localized to the stratum basale and
dermis, and its level was increased by UVB irradiation.
The increase in 8-OHdG-positive cells induced by UVB
irradiation was inhibited by ginsenoside Rb1 (Table 5).
UVB (20mJ/cm2) irradiation reduced the level of Bcl-2
expression in human primary keratinocytes. Conversely,
UVB irradiation had no eﬀect on Bak or Bax expression.
Ginsenoside Rb1 increased the Bcl-2 levels in UVB-treated
human primary keratinocytes at the lower concentrations of
100fg, 10pg, and 1ng/mL (Figure 12).Journal of Biomedicine and Biotechnology 9
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(100 fg/mouse) (1 ng/mouse)
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100 mm
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Figure 11: Photograph showing skin wrinkling induced by chronic UVB irradiation and the eﬀects of topically applied ginsenoside Rb1
[31]. The experiments were performed as described in Figure 9. To evaluate the formation of wrinkles after the UVB irradiation, the UVB-
irradiated dorsal area (site of wrinkles) of each hairless mouse was photographed at 9 weeks.
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Figure 12: Eﬀects of ginsenoside Rb1 on Bax, Bak, and Bcl-2
expression levels in UVB-irradiated human primary keratinocytes
[31]. Human keratinocytes (3 × 105 cells) were seeded in a 100-
mm culture dish and cultured in KG-2 medium for 48h. The
cells were irradiated with UVB (20mJ/cm2) and treated with the
indicated amounts of ginsenoside Rb1 for 24h in KB-2 medium.
After being washed with phosphate-buﬀered saline (PBS, pH 7.0),
the cells were treated with lysed buﬀer. The supernatant obtained
by centrifugation was subjected to a western blot analysis with anti-
Bcl-2, anti-Bax, anti-Bak, and anti-β-actin antibodies.
UVBexposureofskincellsresultsinseveraltypesofDNA
damage such as the formation of the cyclobutane pyrimidine
dimer, pyrimidine pyrimidone photodimers and 8-OHdG
[33–35], and consequently DNA damage induced by long-
termUVexposureleadstoskincarcinogenesis.Furthermore,
there are many reports that apoptotic stimuli such as UV
radiation and tumor necrosis factor-α induce cell death by
activating caspases [36]. Bcl-2 is a member of the large Bcl-2
family and protects cells from apoptosis. On the other hand,
it has been reported that Bax and Bak appear to permeabilize
the outer mitochondrial membrane, allowing the eﬄux
of apoptogenic proteins [37–39] .T h ep r o t e c t i v ee ﬀect of
ginsenoside Rb1 on UVB-mediated apoptosis may be partly
due to the upregulation of Bcl-2 expression in human ker-
atinocytes. Thus, the protective eﬀect of ginsenoside Rb1 on
skin photoaging induced by chronic UVB exposure may be
duetotheincreaseincollagensynthesisand/ortheinhibition
of metalloproteinases expression in dermal ﬁbroblast and
the inhibition of epidermal hyperplasia. Further research is
needed to clarify the mechanism of the protective eﬀect of10 Journal of Biomedicine and Biotechnology
ginsenoside Rb1 on photoaging induced by chronic UVB
irradiation of the skin.
4. Conclusion
The topical application of ginsenoside Rb1 isolated from red
ginseng roots enhances burn wound healing, and ginseno-
side Rb1 prevents chronic UVB-induced skin photoaging,
at very low doses. Further studies will be needed to clarify
the clinical signiﬁcance of these ﬁndings for skin damage
induced by burn wounds or UV irradiation.
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